Co-link Private Equity Co., Ltd and NRC Bio Co., Ltd. signed a contract to acquire 22.17% stake in A1N Inc. from Shin Sung Gas Co., Ltd., Uniquantum Holdings Co., Ltd., Guk-Hwan Woo and Kisoon Kwon for KRW 23.5 billion on October 14, 2017. Under the terms, Co-link Private Equity is acquiring 4.7 million shares at KRW 5000 per share. Co-link Private Equity will make first payment of KRW 5 billion on October 31, 2017 for 1 million shares and will make second payment of KRW 18.5 billion on December 22, 2017 for the remaining 3.7 million shares of A1N. On November 9, 2017, the terms of the deal has been amended in which second payment of KRW 1 billion will paid on November 9, 2017 for acquiring 0.2 million shares and third payment of KRW 17.5 billion won will be paid on December 22, 2017 for acquiring 3.5 million shares. On December 20, 2017, the terms of the deal further revised in which third payment of KRW 2 billion for acquiring 0.4 million shares on December 20, 2017 and fourth payment pf KRW 15.5 billion for acquiring KRW 3.1 million shares on December 20, 2017. Co-link Private Equity Co., Ltd will acquire 3.1 million shares and Co-link Private Equity Co., Ltd will acquire 4.3 million shares. On December 22, 2017, the terms of the deal has been further amended in which third payment of KRW 2 billion will paid for acquiring 0.4 million shares on December 20, 2017 and fourth payment of KRW 15.5 billion won will be paid for acquiring 3.1 million shares on January 31, 2018, Gukhwan Woo owned approximately 3 million shares and post the sale will hold 1.2 million shares, Kisoon Kwon owned 1.3 million shares and post deal will hold 0.3 million shares of A1N. Kwon, Kisoon will sell 1 million shares. As on December 22, 2017, the terms of the deal have been amended, fourth payment of KRW 15.5 billion representing 3.1 million shares will be paid on January 31, 2018. If Co-link Private Equity fails to pay the first sale and the second sale amount within the time limit, the contract will be terminated and the stocks traded on each sale will not be restored to their original value. As per the amendment on January 23, 2018, the terms of the transaction were revised and Co-link Private Equity Co., Ltd. and NRC Bio Co., Ltd. will now acquire 2.6 million shares of WFM Inc. The forth payment of KRW 600 million is scheduled to be paid on January 22, 2018 to Co-link Private Equity Co., Ltd. for the acquisition of 0.12 million shares and the fifth payment of KRW 4.5 billion is scheduled to be paid to Co-link Private Equity Co., Ltd. on January 31, 2018 for the acquisition of 0.9 million shares. As per the amendment on January 24, 2018, the terms of the transaction were revised and Co-link Private Equity Co., Ltd. and NRC Bio Co., Ltd. will now acquire 2.76 million shares of WFM Inc. Woo, Guk-Hwan and three others have signed a contract to sell 2.76 million shares to Co-link Private Equity Co., Ltd. The sixth payment of KRW 2.2 billion is scheduled on January 24, 2018 to Co-link Private Equity Co., Ltd. for the acquisition of 0.44 million shares. After the conclusion of the contract, A1N will hold the extraordinary shareholders' meeting and the person appointed by Co-link Private Equity will be appointed as the Director and the auditor. The scheduled change date for the deal is December 22, 2017. As per the amended terms of the transaction, scheduled change date for the deal is January 31, 2018. As per the amendment, the transaction is expected to complete on January 24, 2018. Co-link Private Equity Co., Ltd and NRC Bio Co., Ltd. cancelled the acquisition of 22.17% stake in A1N Inc. from Shin Sung Gas Co., Ltd., Uniquantum Holdings Co., Ltd., Guk-Hwan Woo and Kisoon Kwon on October 14, 2018.